Targeted Therapies for Triple-Negative Breast Cancer

Article Properties

Language

English
DOI (url)

10.1007/s11864-019-0682-x
Publication Date

2019/11/01
Journal

Current Treatment Options in Oncology
Indian UGC (Journal)
Refrences

33
Citations

205
Tomas G. Lyons

Cite

Lyons, Tomas G. “Targeted Therapies for Triple-Negative Breast Cancer”. Current Treatment Options in Oncology, vol. 20, no. 11, 2019, https://doi.org/10.1007/s11864-019-0682-x.

Lyons, T. G. (2019). Targeted Therapies for Triple-Negative Breast Cancer. Current Treatment Options in Oncology, 20(11). https://doi.org/10.1007/s11864-019-0682-x

Lyons TG. Targeted Therapies for Triple-Negative Breast Cancer. Current Treatment Options in Oncology. 2019;20(11).

Journal Categories

Medicine

Internal medicine

Neoplasms

Tumors

Oncology

Including cancer and carcinogens

Medicine

Medicine (General)

Refrences

Refrences Analysis

Category	Category Repetition
Medicine: Medicine (General)	20
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens	8
Medicine: Internal medicine	5
Science: Biology (General): Genetics	1

The category Medicine: Medicine (General) 20 is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine The chart below illustrates the number of referenced publications per year.

Refrences used by this article by year

Citations

Citations Analysis

Category	Category Repetition
Medicine: Medicine (General)	75
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens	59
Science: Biology (General)	47
Medicine: Therapeutics. Pharmacology	34
Science: Chemistry	30

The first research to cite this article was titled Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature and was published in 2020. The most recent citation comes from a 2024 study titled Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature . This article reached its peak citation in 2022 , with 70 citations.It has been cited in 143 different journals, 27% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 9 citations. The chart below illustrates the annual citation trends for this article.